Sporadic Amplification of the HER2/neu Protooncogene in Adenocarcinomas of Various Tissues

M. Tal, Z. Josefberg, M. Wetzler, A. Deutch, M. Gutman, D. Assaf, R. Kris, Y. Shiloh, D. Givol, J. Schlessinger

Research output: Contribution to journalArticlepeer-review

137 Scopus citations


The HER2/neu protooncogene was found to be amplified in 6 of 109 primary adenocarcinoma tumors. No HER2/neu amplification was found in 29 other primary nonadenocarcinomatous tumors. In two colon tumors, in addition to the amplification, DNA rearrangement of HER2/neu gene was also observed. The rearrangement was explored in detail in one tumor and it was shown to be confined to the 3’ region of the gene. Moreover, this tumor expressed an aberrant HER2/neu polypeptide with a molecular weight of 190,000, which is larger by approximately 5,000 than the molecular weight of the normal HER2/nem protein. The aberrant HER2/neu protein was immunoprecipitated with site-specific antibodies against a synthetic peptide from the COOH-terminal end of the normal HER2/neu protein; it also displayed intrinsic protein tyrosine kinase activity leading to self-phosphorylation.

Original languageEnglish
Pages (from-to)1517-1520
Number of pages4
JournalCancer Research
Issue number6
StatePublished - 1988


FundersFunder number
National Cancer InstituteR01CA025820


    Dive into the research topics of 'Sporadic Amplification of the HER2/neu Protooncogene in Adenocarcinomas of Various Tissues'. Together they form a unique fingerprint.

    Cite this